JAVELIN BRCA/ATM: A phase 2 trial of avelumab (anti-PD-L1) plus talazoparib (PARP inhibitor) in patients with advanced solid tumors with a BRCA1/2 or ATM defect Meeting Abstract
| Authors: | Hyman, D. M.; Zelnak, A. B.; Bauer, T. M.; Ulahannan, S. V.; Ford, J. M.; Cesari, R.; Hoyle, M.; Chappey, C.; Stewart, R.; Conte, U.; Yap, T. A. |
| Abstract Title: | JAVELIN BRCA/ATM: A phase 2 trial of avelumab (anti-PD-L1) plus talazoparib (PARP inhibitor) in patients with advanced solid tumors with a BRCA1/2 or ATM defect |
| Meeting Title: | 55th Annual Meeting of the American Society of Clinical Oncology (ASCO) |
| Journal Title: | Journal of Clinical Oncology |
| Volume: | 37 |
| Issue: | 15 Suppl. |
| Meeting Dates: | 2019 May 31-Jun 4 |
| Meeting Location: | Chicago, IL |
| ISSN: | 0732-183X |
| Publisher: | American Society of Clinical Oncology |
| Date Published: | 2019-05-20 |
| Start Page: | 144s |
| Language: | English |
| ACCESSION: | WOS:000487345803277 |
| DOI: | 10.1200/JCO.2019.37.15_suppl.TPS2660 |
| PROVIDER: | wos |
| Notes: | Meeting Abstract: TPS2660 -- Source: Wos |
